← All patient guides

Prior authorization with Foundation resources

Content note: Educational content aligned with publicly available patient materials from the Crohn's & Colitis Foundation and other major IBD education sources. Content is used under license from the Foundation for patient education; the Foundation does not endorse IBDPal or MediVue products or services. Last reviewed August 2026. Not individual medical advice.

Educational use only. IBDPal does not provide medical advice, diagnosis, or treatment. Always consult your gastroenterologist or IBD care team for personal decisions.

Selected Crohn's & Colitis Foundation educational content and Marks are used on IBDPal under license. This page explains prior authorization for IBD medications using Crohn's and Colitis Foundation patient navigation concepts and links to official appeals resources. The Foundation does not endorse IBDPal. Education only, not medical advice. Reading outside the United States? This page describes U.S. private insurance and employer plan workflows. For country-neutral questions about biologics and accessing therapy abroad, see our biologic questions for your doctor guide and biologic access outside the U.S. guide at ibdpal.org/guides.

Topics: IBD prior authorization, Crohn's insurance approval, colitis step therapy, biologic prior auth Foundation

What prior authorization means

Insurers often require approval before covering expensive IBD drugs. Prior auth documents medical necessity with charts, labs, and prior therapies tried.

Delays can interrupt infusions or injections. Start paperwork early when switching biologics. Symptom patterns tracked over several days are more useful to your clinician than a single snapshot.

Foundation education helps patients understand the process without offering legal advice. Discuss how this topic applies to your current disease activity with your gastroenterologist. Logging patterns in IBDPal or a notebook helps clinicians see trends beyond a single visit. Your GI team can adjust recommendations based on labs, imaging, and symptom trends. Second opinions are reasonable when plans feel unclear or symptoms persist despite treatment. If symptoms worsen while you try these steps, contact your clinic using your flare pathway.

Information to gather

Collect diagnosis codes, colonoscopy reports, calprotectin or CRP trends, and medication history including failures or intolerances.

Ask your clinic which staff handles prior auth. Sign releases so they can speak with insurers. Write down questions for your gastroenterologist before each visit so limited appointment time is used well.

Keep fax numbers and reference IDs for every call. Bring these observations to your next IBD appointment so your team can personalize advice. Children, older adults, and post-surgical patients may need modified guidance from specialists. Patient education supports shared decision making; it does not replace individual medical assessment. Discuss how this topic applies to your current disease activity with your gastroenterologist. Logging patterns in IBDPal or a notebook helps clinicians see trends beyond a single visit.

Step therapy and appeals

Step therapy rules may require trying specific drugs first. Safe Step Act reforms vary by state and plan.

Denials are common. Appeals with physician letters and symptom logs often succeed on second review. Medication adherence and follow-up labs are as important as diet changes for many IBD patients.

Foundation appeal letter templates provide starting language your doctor personalizes. Your GI team can adjust recommendations based on labs, imaging, and symptom trends. Second opinions are reasonable when plans feel unclear or symptoms persist despite treatment. If symptoms worsen while you try these steps, contact your clinic using your flare pathway. Bring these observations to your next IBD appointment so your team can personalize advice. Children, older adults, and post-surgical patients may need modified guidance from specialists.

Patient assistance and copay programs

Manufacturer copay cards and foundation assistance funds help qualifying patients during auth delays.

Financial counselors at infusion centers know program eligibility. Tell your team about travel, work stress, sleep changes, and menstrual cycle timing when symptoms shift.

Document household income and insurance type accurately on applications. Patient education supports shared decision making; it does not replace individual medical assessment. Discuss how this topic applies to your current disease activity with your gastroenterologist. Logging patterns in IBDPal or a notebook helps clinicians see trends beyond a single visit. Your GI team can adjust recommendations based on labs, imaging, and symptom trends. Second opinions are reasonable when plans feel unclear or symptoms persist despite treatment.

Staying on therapy during delays

Never stop biologics without clinician guidance while waiting on auth.

Clinics may provide samples or bridge doses when available. Bring prior colonoscopy, imaging, and pathology reports when seeing a new IBD specialist.

Escalate to plan medical directors with your gastroenterologist if delays risk harm. If symptoms worsen while you try these steps, contact your clinic using your flare pathway. Bring these observations to your next IBD appointment so your team can personalize advice. Children, older adults, and post-surgical patients may need modified guidance from specialists. Patient education supports shared decision making; it does not replace individual medical assessment. Discuss how this topic applies to your current disease activity with your gastroenterologist.

Practical tips

  • Start prior auth before your last dose runs out.
  • Save every denial letter.
  • Ask insurers for case manager names.
  • Use Foundation appeal templates with your doctor.
  • Log symptoms during auth delays for appeals.

Common questions

How long does prior auth take?

Days to weeks depending on plan and drug. Urgent requests may expedite.

Can I pay cash to skip auth?

Sometimes, but costs are high. Discuss with your clinic.

Who writes appeal letters?

Your prescriber, often with templates from Foundation or clinic legal teams.

Free tools on ibdpal.org

Track nutrition and symptoms, explore our community map, read the blog, or download the IBDPal iOS app.

Explore IBDPal →

Educational only. IBDPal does not provide medical advice, diagnosis, or treatment. Always consult your gastroenterologist or IBD care team for personal decisions.